Prior reports demonstrate a near-zero risk of prostate-cancer death among patients with very low-risk tumours managed on active surveillance (AS). However, outcomes from an AS cohort in Sweden suggest that observing men with low-risk and intermediate-risk tumours carries a small — but significant — risk of treatment failure and death from prostate cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cooperberg, M. R. & Carroll, P. R. Trends in management for patients with localized prostate cancer, 1990–2013. JAMA 314, 80–82 (2015).
Klotz, L. et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J. Clin. Oncol. 33, 272–277 (2015).
Tosoian, J. J. et al. Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer. J. Clin. Oncol. 33, 3379–3385 (2015).
Godtman, R. A. et al. Long-term results of active surveillance in the Göteborg randomized, population-based prostate cancer screening trial. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2016.03.048 (2016).
Babaian, R. J. et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J. Urol. 163, 152–157 (2000).
Siddiqui, M. M. et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313, 390–397 (2015).
Filson, C. P. et al. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies. Cancer 122, 884–892 (2016).
Bostrom, P. J. et al. Genomic predictors of outcome in prostate cancer. Eur. Urol. 68, 1033–1044 (2015).
Newcomb, L. F. et al. Outcomes of active surveillance for clinically localized prostate cancer in the prospective, multi-institutional Canary PASS cohort. J. Urol. 195, 313–320 (2016).
Bruinsma, S. M. et al. Active surveillance for low risk prostate cancer: the study protocol of the Movember Global Action Plan 3 (GAP3) project. Eur. Urol. Supp. 14, e1036–e1036a (2015).
Acknowledgements
The author would like to thank Dr Hung-Jui Tan for editorial input for this commentary.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Filson, C. Caveat Emptor — long-term outcomes in the Göteborg active surveillance cohort. Nat Rev Urol 13, 307–308 (2016). https://doi.org/10.1038/nrurol.2016.85
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2016.85
